Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 832

1.

Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.

Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A.

Mol Cell Biol. 2003 Jul;23(13):4494-510.

2.

Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.

Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K.

J Biol Chem. 2004 Sep 24;279(39):40267-75. Epub 2004 May 18.

3.

Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).

Pardali K, Kowanetz M, Heldin CH, Moustakas A.

J Cell Physiol. 2005 Jul;204(1):260-72.

PMID:
15690394
4.

Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling.

Rodriguez C, Huang LJ, Son JK, McKee A, Xiao Z, Lodish HF.

J Biol Chem. 2001 Aug 10;276(32):30224-30. Epub 2001 May 31.

5.

Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.

Harada J, Kokura K, Kanei-Ishii C, Nomura T, Khan MM, Kim Y, Ishii S.

J Biol Chem. 2003 Oct 3;278(40):38998-9005. Epub 2003 Jul 21.

6.

Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.

Kahata K, Hayashi M, Asaka M, Hellman U, Kitagawa H, Yanagisawa J, Kato S, Imamura T, Miyazono K.

Genes Cells. 2004 Feb;9(2):143-51.

7.

Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.

Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I.

J Biol Chem. 2003 Oct 31;278(44):43470-9. Epub 2003 Aug 13.

9.
10.

The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.

Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC.

J Biol Chem. 2004 Oct 8;279(41):42492-502. Epub 2004 Jul 28.

11.

The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.

Zhang Y, Musci T, Derynck R.

Curr Biol. 1997 Apr 1;7(4):270-6.

12.
13.

Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A.

Mol Cell Biol. 2000 Nov;20(21):8103-11.

14.
16.

Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Pardali K, Kurisaki A, Morén A, ten Dijke P, Kardassis D, Moustakas A.

J Biol Chem. 2000 Sep 22;275(38):29244-56.

17.
18.

Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells.

Ogawa K, Chen F, Kim YJ, Chen Y.

J Biol Chem. 2003 Aug 8;278(32):30373-81. Epub 2003 May 15.

19.

A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.

Kato Y, Habas R, Katsuyama Y, Näär AM, He X.

Nature. 2002 Aug 8;418(6898):641-6. Epub 2002 Jul 24.

PMID:
12167862
20.

Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.

Li C, Zhu NL, Tan RC, Ballard PL, Derynck R, Minoo P.

J Biol Chem. 2002 Oct 11;277(41):38399-408. Epub 2002 Aug 2.

Supplemental Content

Support Center